ACOG Updated Cervical Screening Guidelines Include Digene DNAwithPap
This article was originally published in The Gray Sheet
Executive Summary
Revised cervical cancer screening guidelines from the American College of Obstetricians & Gynecologists could facilitate adoption of Digene's recently approved DNAwithPap test for primary screening
You may also be interested in...
Cervical Cancer Screening Three-Year Interval Risks Weighed In NEJM Study
Triennial cervical cancer screening of women aged 30-64 who have had three previous negative Pap tests is associated with only slight "excess risk," compared with annual screening for three years, according to a study in the Oct. 16 New England Journal of Medicine
Cervical Cancer Screening Three-Year Interval Risks Weighed In NEJM Study
Triennial cervical cancer screening of women aged 30-64 who have had three previous negative Pap tests is associated with only slight "excess risk," compared with annual screening for three years, according to a study in the Oct. 16 New England Journal of Medicine
HPV DNA Pap Test Approved As Primary Screen; New Guidelines Expected
Digene is evaluating various methods of marketing its human papillomavirus (HPV) test to ob/gyn physicians following expanded approval for primary cervical cancer screening March 31